Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Heterotopic Ossification in the Skeletal Muscle and Endothelial Cells Recruitment to Chondrogenesis Are Enhanced by Monocyte/Macrophage Depletion.
Tirone M, Giovenzana A, Vallone A, Zordan P, Sormani M, Nicolosi PA, Meneveri R, Gigliotti CR, Spinelli AE, Bocciardi R, Ravazzolo R, Cifola I, Brunelli S. Tirone M, et al. Among authors: nicolosi pa. Front Immunol. 2019 Jul 19;10:1640. doi: 10.3389/fimmu.2019.01640. eCollection 2019. Front Immunol. 2019. PMID: 31396210 Free PMC article.
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
Cattaruzza S, Nicolosi PA, Braghetta P, Pazzaglia L, Benassi MS, Picci P, Lacrima K, Zanocco D, Rizzo E, Stallcup WB, Colombatti A, Perris R. Cattaruzza S, et al. Among authors: nicolosi pa. J Mol Cell Biol. 2013 Jun;5(3):176-93. doi: 10.1093/jmcb/mjt010. Epub 2013 Apr 3. J Mol Cell Biol. 2013. PMID: 23559515 Free PMC article.
Theranostic impact of NG2/CSPG4 proteoglycan in cancer.
Nicolosi PA, Dallatomasina A, Perris R. Nicolosi PA, et al. Theranostics. 2015 Feb 15;5(5):530-44. doi: 10.7150/thno.10824. eCollection 2015. Theranostics. 2015. PMID: 25767619 Free PMC article. Review.
Glyoxal acid-free (GAF) histological fixative is a suitable alternative to formalin: results from an open-label comparative non-inferiority study.
Ryska A, Sapino A, Landolfi S, Valero IS, Cajal SRY, Oliveira P, Detillo P, Lianas L, Frexia F, Nicolosi PA, Monti T, Bussolati B, Marchiò C, Bussolati G. Ryska A, et al. Among authors: nicolosi pa. Virchows Arch. 2023 Nov 24. doi: 10.1007/s00428-023-03692-6. Online ahead of print. Virchows Arch. 2023. PMID: 37996705 Free article.